- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Caforio Appointed BMS CEO
Bristol-Myers Squibb (BMS) has named former chief operating officer Giovanni Caforio as the company’s new CEO.
Bristol-Myers Squibb (BMS) has named former chief operating officer Giovanni Caforio as the company’s new CEO, effective May 5. He will replace Lamberto Andreotti, who will become executive chairman of the board. Caforio has led transformational deals in BMS’s U.S. and global oncology departments. He has also served at the company as chief commercial officer and chief operating officer and has been a member of its senior management team since 2011.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.
